Case Against AMERCO (UHAL) Dismissed with Prejudice
Tweet Send to a FriendGet Alerts UHAL Hot Sheet
Price: $173.15 +1.29%
Overall Analyst Rating:
NEUTRAL (= Flat)
Dividend Yield: 2.9%
EPS Growth %: +49.6%
Overall Analyst Rating:
NEUTRAL (= Flat)
Dividend Yield: 2.9%
EPS Growth %: +49.6%
Trade UHAL Now!
MERCO (Nasdaq: UHAL), parent of U-Haul International, Inc., and Amerco Real Estate announced all remaining plaintiffs in the AMERCO shareholder derivative litigation filed a Dismissal with Prejudice. This terminates with prejudice such litigation in its entirety.
The suit, which was captioned Paul F. Shoen vs. SAC Holding Corporation et al., CV 02-05602, consolidated with CV02-06331, CV03-02486 and CV03-02617, Second Judicial District Court, Washoe County, Nevada, had been pending against AMERCO, SAC Holding Corporation and certain of its affiliates, and certain current and former members of the AMERCO Board of Directors, as defendants. There is no fee or payment of any form to the plaintiffs in connection with their Dismissal with Prejudice of the litigation.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The suit, which was captioned Paul F. Shoen vs. SAC Holding Corporation et al., CV 02-05602, consolidated with CV02-06331, CV03-02486 and CV03-02617, Second Judicial District Court, Washoe County, Nevada, had been pending against AMERCO, SAC Holding Corporation and certain of its affiliates, and certain current and former members of the AMERCO Board of Directors, as defendants. There is no fee or payment of any form to the plaintiffs in connection with their Dismissal with Prejudice of the litigation.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Ackman's Pershing Square Says Herbalife (HLF) Refuses to Release Sales Data, Calls for Probe
- Royalty Pharma withdraws judicial review, says Elan (ELN) bid lapsed - Bloomberg
- Rambus (RMBS) Enters License with STMicro (STM)
Create E-mail Alert Related Categories
Litigation
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
